Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Paul Billings: May 7, 2014

Premium

Genome interpretation firm Omicia has hired Paul Billings as its new chief medical officer. Billings will also serve on the firm's scientific advisory board.

He comes to Omicia from Life Technologies, which was acquired by Thermo Fisher Scientific and where he was chief medical officer. Before that, Billings was chief scientific officer of the Genomic Medicine Institute at El Camino Hospital, and CEO of CELLective Dx Corporation. Billings is a genomics industry leader and has held executive-level positions at numerous top life sciences firms and organizations.

Filed under

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.